Study on Tear Proteins in Diabetic Retinopathy of Type 2 Diabetics
Tear Proteins and Diabetic Retinopathy
Sponsor: Dow University of Health Sciences
A observational or N/A phase clinical study on Diabetes Mellitus, this trial is ongoing. The trial is conducted by Dow University of Health Sciences and has accumulated 6 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Unknown Status NA
First recorded
Jan 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Dow University of Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .